2Vzquez Mellado J, Alvaerz Hernmdez E, Burgos-Vargas R, et al. Primary prevention in rheumatology:the importance of hyperuricemia[ J]. Best Pract Res Clin Rheumatol,2004,18 (2) :121 -124.
3Rafey MA, Lipkowitz MS, Leal-Pinto E, et al. Uric acid transport [ J ]. Curr Opin Nephrol Hypertens, 2003,12 ( 5 ) : 511 -516.
4Toblli JE, DeRosa G, Lago N. Potassium citrate administra- tion ameliorates tubulointerstitial lesions in rats with uric acid nephropathy[ J]. Clin Nephro1,2001,55 ( 1 ) :59 - 68.
5Pauff JM, Hille R. Inhibition studies of bovine xanthine oxi- dase by lnteolin, silibinin, quercetin, and curcumin [ J ]. J Nat Prod,2009,72(4) :725 -731.
6Yu Z,FongWP,C.heng CH. The dual actions of morin(3,5, 7,2', 4-pentahydroxyflavone ) as a hypouricemic agent : uri- cosuric effect and xanthine oxidase inhibitory activity[ J ]. J Pharmacol Exp Ther,2006,316( 1 ) : 169 - 175.
7Snchez-Lozada LG, Tapia E, Soto V, et al. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in ex- perimental hyperuricaemia [ J ]. Nephrol Dial Transplant, 2008,23(4) :1 179 -1 185.
8Carroll JJ, Coburn H, Douglass R, et al. A simplified alkaline phosphotungstate assay for uric acid in serum [ J ]. Clin Chem,1971,17(3) :158 - 160.
9Haidari F, Rashidi MR, Keshavarz SA, et al. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogen- ase/xanthine oxidase activities in hyperuricemic rats [ J ]. Pak J Biol Sci,2008,11 (14) :1 779 -1 784.
